Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Liraglutide for Sale > Keeping Fitness peptides product with CAS 204656-20-2 Liraglutide /GLP-1 2mg 5mg 10mg Comings
Keeping Fitness peptides product with CAS 204656-20-2 Liraglutide /GLP-1 2mg 5mg 10mg Comings buy - large image1
Keeping Fitness peptides product with CAS 204656-20-2 Liraglutide /GLP-1 2mg 5mg 10mg Comings buy - image1
Keeping Fitness peptides product with CAS 204656-20-2 Liraglutide /GLP-1 2mg 5mg 10mg Comings buy - image2
Keeping Fitness peptides product with CAS 204656-20-2 Liraglutide /GLP-1 2mg 5mg 10mg Comings buy - image3
Keeping Fitness peptides product with CAS 204656-20-2 Liraglutide /GLP-1 2mg 5mg 10mg Comings buy - image4
Keeping Fitness peptides product with CAS 204656-20-2 Liraglutide /GLP-1 2mg 5mg 10mg Comings buy - image5
Keeping Fitness peptides product with CAS 204656-20-2 Liraglutide /GLP-1 2mg 5mg 10mg Comings buy - image6

Keeping Fitness peptides product with CAS 204656-20-2 Liraglutide /GLP-1 2mg 5mg 10mg Comings

TDS 28 Inquiries

Unit Price: Get Latest Price
CAS No.:

204656-20-2

Grade:

Top Product

Content:

99%

Port:

shanghai

Brand:

COMINGS

Packaging:

1g,50g,100g,1000g

Price valid (until):

2025-06-26

Company Type:
Trader
Location:
China
Qualification:
Main Products:

semaglutide,tirzepatide,Liraglutide,Retatrutide,5-amino-1MQ,SLU-PP-332

  • Product Description

  • Seller Information

  • Inquiry History

  • Description
    Items Specifications
    CAS:  204656-20-2
    Name:  Liraglutide
    Synonyms Name:  GLP-1
    Molecular formula:  C172H265N43O51
    Molecular Weight:  3751.20000
    Color white


      Product Detail  


    • The Effects Of Liraglutide ?

      Liraglutide, a medication belonging to the class of GLP-1 receptor agonists, has several effects primarily related to its use in managing type 2 diabetes and obesity:

      Blood Sugar Control: Liraglutide works by mimicking the action of the hormone GLP-1, stimulating insulin release in response to elevated blood sugar levels. It also reduces the amount of glucose produced by the liver, helping to lower blood sugar levels. This effect aids in better control of blood sugar in individuals with type 2 diabetes.

      Weight Loss: Liraglutide has been found to promote weight loss, especially in individuals with obesity. Its mechanism of action includes reducing appetite and food intake. It acts on areas of the brain involved in appetite regulation, leading to a feeling of fullness or satiety, which can result in weight loss over time.

      Cardiovascular Benefits: Some studies suggest that liraglutide might have cardiovascular benefits. Research has shown potential reductions in the risk of cardiovascular events in individuals with type 2 diabetes who are at high risk for heart disease.

      Gastrointestinal Effects: Common side effects of liraglutide include nausea, vomiting, and diarrhea, especially when starting the medication. These gastrointestinal effects tend to diminish over time in many individuals.

      Potential for Pancreatitis: While rare, there have been reports of pancreatitis associated with the use of GLP-1 receptor agonists like liraglutide. This risk is generally low but requires monitoring and caution, especially in individuals with a history of pancreatitis.

      Hypoglycemia: Liraglutide has a lower risk of causing hypoglycemia (low blood sugar) compared to some other diabetes medications. However, hypoglycemia can still occur, especially when liraglutide is used in combination with other medications that lower blood sugar.

      The effects and benefits of liraglutide can vary among individuals and might also depend on factors such as dosage, duration of use, and individual health conditions. As with any medication, it's essential to use liraglutide under the guidance of a healthcare professional to monitor its effects, manage potential side effects, and optimize its benefits for an individual's specific medical condition.


      The Side Effects Of Liraglutide

      Liraglutide, a medication used for managing type 2 diabetes and obesity, can have various side effects. While not everyone experiences these side effects, some commonly reported ones include:

      Gastrointestinal Effects: Nausea, vomiting, diarrhea, and sometimes constipation are among the most frequently reported side effects, especially during the initial weeks of treatment. These symptoms tend to improve over time for many individuals.

      Hypoglycemia: Liraglutide has a lower risk of causing hypoglycemia (low blood sugar) compared to certain other diabetes medications. However, hypoglycemia can still occur, particularly when liraglutide is used in combination with other medications that lower blood sugar.

      Headache: Some individuals might experience headaches as a side effect of liraglutide.

      Injection Site Reactions: Irritation, redness, or pain at the site of injection might occur, although this is relatively uncommon.

      Gallbladder Issues: There have been reports of gallbladder-related problems such as gallstones or inflammation in some individuals using liraglutide.

      Pancreatitis: While rare, there have been reports of pancreatitis associated with the use of GLP-1 receptor agonists like liraglutide. This risk is generally low but requires monitoring, especially in individuals with a history of pancreatitis.

      Thyroid Tumors: There have been observations of thyroid C-cell tumors in animal studies with liraglutide. However, the relevance of these findings to humans and the risk for humans remains unclear.

      It's essential to be aware of these potential side effects when starting liraglutide. Not everyone will experience these, and the severity and occurrence of side effects can vary among individuals.

      Always discuss any concerns or side effects with a healthcare professional. They can provide guidance on managing side effects and determine if liraglutide is the most suitable treatment based on an individual's health condition and medical history. Regular monitoring and communication with a healthcare provider are crucial when using liraglutide or any medication for diabetes or obesity management.


      The Packaging Of Liraglutide

      1g,50g,100g,1000g

    Wuhan Comings Biotechnology Co., Ltd. was established in 2016. Since its establishment, the company has always been committed to making more people healthy, making more people young and happy, and providing customers with high-quality and efficient services.

    The company cooperates with biological experts from many universities, adopts modern gene cloning technology and unique purification technology, and strictly controls all aspects. The adipotide we produce are sold well in Europe, Africa, and America, and many customers have given good reviews.

    And our company has storage bases in Shenzhen, Shanghai, Qingdao ports to ensure that all goods can arrive safely, on time and quickly.

    Wuhan Comings Biotechnology Co., Ltd. is looking forward to cooperating with you with professional knowledge, high-quality service and competitive price!

    Shop JBSNF-000088/-Methoxynicotinamide 98% Powder 7150-23-4 COMINGS-Detailed Image 1

    Shop JBSNF-000088/-Methoxynicotinamide 98% Powder 7150-23-4 COMINGS-Detailed Image 2Shop JBSNF-000088/-Methoxynicotinamide 98% Powder 7150-23-4 COMINGS-Detailed Image 3Shop JBSNF-000088/-Methoxynicotinamide 98% Powder 7150-23-4 COMINGS-Detailed Image 4Shop JBSNF-000088/-Methoxynicotinamide 98% Powder 7150-23-4 COMINGS-Detailed Image 5

    Shop Weight Loss GLP-1 Injection Peptide 99% Purity Tirzepatide(LY3298176) Semaglutide/COMINGS-Detailed Image 6

    Certificates
    • Keeping Fitness peptides product with CAS 204656-20-2 Liraglutide /GLP-1 2mg 5mg 10mg Comings Certificates 1

    Basic Info
    Product Name:

    Liraglutide

    Other Name:

    Liraglutide;Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-;Liraglutida;Liraglutida [inn-spanish];Liraglutide [usan:inn];Liraglutidum;Liraglutidum [inn-latin];N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide

    CAS No.:

    204656-20-2

    Molecular Formula:

    C172H265N43O51

    InChIKeys:

    YSDQQAXHVYUZIW-VTFFJMQZNA-N

    Molecular Weight:

    3751.202

    Exact Mass:

    3748.95000

    EC Number:

    810-818-7

    Color/Form:

    White to Off-White

    Characteristics
    PSA:

    1513.76000

    XLogP3:

    6.12960

    Melting Point:

    >182°C (dec.)

    Critical Temperature & Pressure:

    Refrigerator

    Hazard Identification

    Classification of the substance or mixture

    Carcinogenicity, Category 2

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H351 Suspected of causing cancer

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    semaglutide,tirzepatide,Liraglutide,Retatrutide,5-amino-1MQ,SLU-PP-332

    Location:

    No. 1, 19th Floor, Unit 2, Building 5, Southeast Residential Building (Hankou Yujiang Lanting), at the intersection of Hanshi Highway and Fufa South Road, Wuhu Street, Huangpi District, Wuhan City, Hu

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    15

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2023

    We prospectively allocates international cutting-edge production and testing equipment and environmental protection facilities. The 5 production lines can achieve an annual output of 1000Kg. We to be the best chemical manufacture in China,and will become a trustworthy supplier of chemicals for global customers.
    Our main products include peptides, cognitive enhancers, pharmaceutical intermediates, and botanical extracts.
    And our main clients cover: pharmaceutical companies, hospitals, laboratories in higher education institutions, and cosmetic companies.
    Since its establishment, our company's products have been exported to regions including Europe, the Americas, the Middle East and so on. Our commitment to high product quality and excellent after-sales service has provided customers with a positive experience.
    Wuhan Comings Biotechnology Co., Ltd. is looking forward to cooperating with you with professional knowledge, high-quality service and competitive price!
  • Inquiry History
    28 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    China factory wholesale price supply high purity 99% cas 204656-20-2 Liraglutide injection

    50 KG Sep 30, 2023
    India

    Liraglutide

    1.00 KG Oct 8, 2024
    India

    Liraglutide-USP

    150.00 G Oct 10, 2023
    United States

    Mic (Lipo C with B12), VIP, Ss31, glutathione and, Reta

    50 MG Mar 4, 2026
    India

    liraglutide

    1 KG Feb 25, 2026
    United States

    liraglutide

    Jan 21, 2026
    United States

    liraglutide

    1 MT Nov 22, 2025
    Reunion Island

    Liraglutide

    1 G Apr 14, 2025
    United States

    Liraglut

    1 MT Feb 9, 2025
    Israel

    Liraglutide

    1 G Aug 26, 2024
    India

    Liraglutide

    10 G Jun 26, 2024
    India

    Liraglutide

    100 G Mar 4, 2024
    United States

    Semaglutide Liraglutide powder

    10 G Feb 20, 2024
    United States

    MIC

    2 MT May 20, 2026
    Canada

    Liraglutide

    1 KG Dec 8, 2025
    Brazil

    Liraglutida

    1 G Sep 29, 2025
    United States

    Liraglutide

    1 KG Aug 13, 2025
    Sweden

    liraglutide

    1 KG Aug 4, 2025
    Pakistan

    liraglutide injection

    50 KG Jan 21, 2025
    India

    Liraglutide

    10 MG Jul 17, 2024
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.